{"id":"CVE-2022-46355","aliases":["EUVD-2022-49171","GHSA-rmxv-hrvc-7c4x"],"status":"published","title":"A vulnerability has been identified in SCALANCE X204RNA (HSR) (All versions \u003c V3.2.7), SCALANCE...","description":"A vulnerability has been identified in SCALANCE X204RNA (HSR) (All versions \u003c V3.2.7), SCALANCE X204RNA (PRP) (All versions \u003c V3.2.7), SCALANCE X204RNA EEC (HSR) (All versions \u003c V3.2.7), SCALANCE X204RNA EEC (PRP) (All versions \u003c V3.2.7), SCALANCE X204RNA EEC (PRP/HSR) (All versions \u003c V3.2.7). The affected products are vulnerable to an \"Exposure of Sensitive Information to an Unauthorized Actor\" vulnerability by leaking sensitive data in the HTTP Referer.","severity":{"version":"3.1","score":7.5,"vector":"CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N","level":"high","assessor":"primary","from":"nvd"},"epss":{"day":"2026-11-10","score":0.00644,"percentile":0.51226,"model":"v2026.06.15"},"facts":{"in_kev":false,"known_exploited":false,"public_exploit":false,"fix_available":false},"cwes":["CWE-200"],"published":"2022-12-13T00:00:00Z","modified":"2026-06-17T05:11:36Z","products":[{"vendor":"siemens","product":"6gk5204-0ba00-2kb2_firmware"},{"vendor":"siemens","product":"6gk5204-0ba00-2mb2_firmware"},{"vendor":"siemens","product":"6gk5204-0bs00-2na3_firmware"},{"vendor":"siemens","product":"6gk5204-0bs00-3la3_firmware"},{"vendor":"siemens","product":"6gk5204-0bs00-3pa3_firmware"},{"vendor":"siemens","product":"scalance x204rna (hsr)"},{"vendor":"siemens","product":"scalance x204rna (prp)"},{"vendor":"siemens","product":"scalance x204rna eec (hsr)"},{"vendor":"siemens","product":"scalance x204rna eec (prp)"},{"vendor":"siemens","product":"scalance x204rna eec (prp/hsr)"}],"references":[{"url":"https://cert-portal.siemens.com/productcert/pdf/ssa-363821.pdf","tags":["x_transferred","Patch","Vendor Advisory"]},{"url":"https://nvd.nist.gov/vuln/detail/CVE-2022-46355"},{"url":"https://github.com/advisories/GHSA-rmxv-hrvc-7c4x"}],"sources":{"cve":[{"id":"CVE-2022-46355","description":"A vulnerability has been identified in SCALANCE X204RNA (HSR) (All versions \u003c V3.2.7), SCALANCE X204RNA (PRP) (All versions \u003c V3.2.7), SCALANCE X204RNA EEC (HSR) (All versions \u003c V3.2.7), SCALANCE X204RNA EEC (PRP) (All versions \u003c V3.2.7), SCALANCE X204RNA EEC (PRP/HSR) (All versions \u003c V3.2.7). The affected products are vulnerable to an \"Exposure of Sensitive Information to an Unauthorized Actor\" vulnerability by leaking sensitive data in the HTTP Referer.","status":"published","published":"2022-12-13T00:00:00Z","modified":"2025-04-22T14:40:09.057Z","cvss":[{"version":"3.1","score":7.5,"vector":"CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N","level":"high","assessor":"adp"}],"cwes":["CWE-200"],"updated_at":"2026-11-02T14:34:31.840191Z"}],"euvd":[{"id":"EUVD-2022-49171","description":"A vulnerability has been identified in SCALANCE X204RNA (HSR) (All versions \u003c V3.2.7), SCALANCE X204RNA (PRP) (All versions \u003c V3.2.7), SCALANCE X204RNA EEC (HSR) (All versions \u003c V3.2.7), SCALANCE X204RNA EEC (PRP) (All versions \u003c V3.2.7), SCALANCE X204RNA EEC (PRP/HSR) (All versions \u003c V3.2.7). The affected products are vulnerable to an \"Exposure of Sensitive Information to an Unauthorized Actor\" vulnerability by leaking sensitive data in the HTTP Referer.","status":"published","published":"2022-12-13T00:00:00Z","modified":"2025-04-22T14:40:09Z","cvss":[{"version":"3.1","score":7.5,"vector":"CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N","level":"high"}],"updated_at":"2026-11-02T20:52:17.280298Z"}],"ghsa":[{"id":"GHSA-rmxv-hrvc-7c4x","title":"A vulnerability has been identified in SCALANCE X204RNA (HSR) (All versions \u003c V3.2.7), SCALANCE...","description":"A vulnerability has been identified in SCALANCE X204RNA (HSR) (All versions \u003c V3.2.7), SCALANCE X204RNA (PRP) (All versions \u003c V3.2.7), SCALANCE X204RNA EEC (HSR) (All versions \u003c V3.2.7), SCALANCE X204RNA EEC (PRP) (All versions \u003c V3.2.7), SCALANCE X204RNA EEC (PRP/HSR) (All versions \u003c V3.2.7). The affected products are vulnerable to an \"Exposure of Sensitive Information to an Unauthorized Actor\" vulnerability by leaking sensitive data in the HTTP Referer.","status":"published","published":"2022-12-13T18:30:34Z","modified":"2024-04-04T03:14:10Z","cvss":[{"version":"3.1","score":7.5,"vector":"CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N","level":"high"}],"cwes":["CWE-200"],"updated_at":"2026-11-02T14:56:14.332077Z"}],"nvd":[{"id":"CVE-2022-46355","description":"A vulnerability has been identified in SCALANCE X204RNA (HSR) (All versions \u003c V3.2.7), SCALANCE X204RNA (PRP) (All versions \u003c V3.2.7), SCALANCE X204RNA EEC (HSR) (All versions \u003c V3.2.7), SCALANCE X204RNA EEC (PRP) (All versions \u003c V3.2.7), SCALANCE X204RNA EEC (PRP/HSR) (All versions \u003c V3.2.7). The affected products are vulnerable to an \"Exposure of Sensitive Information to an Unauthorized Actor\" vulnerability by leaking sensitive data in the HTTP Referer.","status":"published","published":"2022-12-13T16:15:25.977Z","modified":"2026-06-17T05:11:36.497Z","cvss":[{"version":"3.1","score":7.5,"vector":"CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N","level":"high","assessor":"primary"},{"version":"3.1","score":7.5,"vector":"CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N","level":"high","assessor":"secondary"}],"cwes":["CWE-200"],"updated_at":"2026-11-02T14:07:33.649381Z"}]}}